1. South Korea Stocks

  2. •

    Consumer non-durables

  3. •

    Household/Personal care
Leaders Cosmetics Co., Ltd

Leaders Cosmetics Co., Ltd

KKRX:016100
1,139.00
KRW
+28.00
(+2.52%)
-449.09EPS
29.09BMarket Cap
Leaders Cosmetics Co., Ltd
KRX:016100
(Korea Stock Exchange)

Recent

price

1,139.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
2,372.77
2,724.63
3,431.15
4,252.66
7,052.14
10,155.28
10,650.43
8,224.78
8,126.32
5,538.83
5,425.95
4,853.18
4,664.19
3,824.32
3,999.78
3,726.61
3,653.65
Revenue per Share
-24
893.95
-281.66
-199
913
886
273
-346
-499
-3,208
1,313
-220
-37
13
-174
-454
-449.83
Basic EPS, GAAP
-40.64
-939.78
-671.15
158.55
1,074.8
-1,752.13
759.38
-815.52
-429.03
-1,441.21
-619.34
72.99
105.05
-404.51
-235.34
-352.34
-370.12
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
1,895.31
2,848.11
2,490.52
2,498.62
3,423.48
4,831.77
5,216.46
4,716.98
4,388.2
1,660.17
3,888.32
3,038.75
2,357.25
2,408.76
2,036.09
1,494.99
3,217.28
Book Value per Share
1,895.31
2,807.44
2,408.62
2,424.19
3,344.62
4,735.14
5,066.07
4,550.69
4,239.67
1,547.98
3,796.64
2,964.33
2,294.09
2,346.99
1,974.41
1,435.8
3,169.83
Tangible Book Value per Share
17
17
17
17
17
17
17
17
17
17
17
18
19
18
18
18
18
Basic Weighted Avg Shares
39,503
45,125
58,928
73,093
120,039
172,780
181,307
139,935
139,186
95,635
93,720
87,431
86,658
69,279
73,499
68,314
67,202
Sales/Revenue/Turnover
1.06
0.74
1.47
3.02
18.45
19.93
7.65
-0.18
-9.79
-28.97
-12.19
-4.79
0.58
-6.22
-3.95
-10.38
-11.22
Operating Margin (%)
1,063
951
2,413
3,235
3,736
4,439
5,190
5,550
6,015
7,769
7,084
3,772
2,960
2,011
1,881
2,509
2,558
Depreciation Expense
-400
14,806
-4,837
-3,420
15,541
15,074
4,647
-5,887
-8,547
-55,390
22,679
-3,963
-687
235
-3,197
-8,322
-8,274
Net Income, GAAP
- -
21.57
- -
- -
22.05
52.93
33.9
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-1.01
32.81
-8.21
-4.68
12.95
8.72
2.56
-4.21
-6.14
-57.92
24.2
-4.53
-0.79
0.34
-4.35
-12.18
-12.31
Profit Margin (%)
11,597
4,415
8,738
8,667
19,669
59,167
50,721
53,905
18,732
6,416
-22,015
-11,728
-10,142
-5,125
-11,579
-15,828
-16,026
Working Capital
- -
5,672
12,206
5,867
2,868
25,639
11,191
36,631
10,000
26,282
6,119
79
74
3,267
317
3,280
3,206
LT Debt
31,235
48,915
44,840
46,219
63,991
108,518
120,173
109,151
98,664
49,038
68,456
55,718
43,336
44,219
37,407
28,658
61,536
Total Equity
- -
0.61
- -
- -
24.35
13.56
7.85
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
32.73
- -
- -
20.73
18.75
1.6
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
-1.27
36.94
-10.55
-7.98
30.56
21.26
5.39
-6.9
-10.86
-105.2
46.92
-6.42
-1.39
0.54
-7.85
-25.26
-17.16
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
25,282
26,058
27,388
LT Borrowings
3,000
3,000
2,986
LT Finance Leases
163
280
220
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
18
19
19
Market Capitalization
42,906
36,922
29,091

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
21,057
19,090
19,134
Cash, Cash Equivalents & STI
6,310
5,565
5,065
Accounts Receivable, Net
8,389
7,694
7,439
Inventories
5,108
5,020
4,587
Total Current Liabilities
34,326
34,919
35,159
Payables & Accruals
- -
- -
- -
ST Debt
25,282
26,058
27,388
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-9.63%
-15.52%
-23.39%
Free Cash Flow
-74.71%
-106.19%
49.36%
Net Income, GAAP
-147.53%
-326.36%
160.29%
Sales/Revenue/Turnover
-8.03%
-5.72%
-7.05%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
18,115
18,964
17,796
18,624
73,499
2025
18,358
19,510
18,857
11,588
68,314
2026
17,247
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-28
31
-49
-127.49
-174
2025
-109
-38.28
-93.95
-213.1
-454
2026
-104.6
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Procter & Gamble Company (The) (NYSE:PG)
Cupid Limited (NSE:CUPID)
Hindustan Unilever Limited (NSE:HINDUNILVR)
Colgate-Palmolive (India) Limited (NSE:COLPAL)
Dabur India Limited (NSE:DABUR)
e.l.f. Beauty, Inc. (NYSE:ELF)
Business
Leaders Cosmetics Co., Ltd. (KOSDAQ: 016100) manufactures and sells dermatology-based cosmetic products in South Korea and select international markets. The company offers an extensive range of skincare solutions including cleansing products, skin care essentials such as toners and essences, facial sheet masks renowned for pioneering technology, mask/pack treatments, sun care formulations, makeup items, and curated sets; its flagship brands encompass Insolution for personalized natural-ingredient regimens addressing under-skin concerns, Mediu delivering optimized daily textures and functions, and Life Source featuring innovative anti-aging products with patented AAPE (Advanced Adipose-derived stem cell Protein Extract) for skin regeneration and rejuvenation. Founded in 2004 by leading dermatologists from Seoul National University and headquartered at The Classic #C404, 90 Neungdong-ro, Gwangjin-gu, Seoul, South Korea, the company previously operated as Sansung Life & Science Co., Ltd. before rebranding to Leaders Cosmetics Co., Ltd. in April 2016, with branch offices and warehouses in the United States, Switzerland, and China to support global distribution through retail, online, and direct channels targeting consumers seeking K-beauty standards. Recent developments include the launch of new product lines such as the PEEL STEP series comprising Panthenol Soft Peeling Pads, Cica Mild Peeling Pads, and PHA Deep Peeling Pads, alongside expanded availability on platforms like Amazon and its official websites, reflecting ongoing innovation in clinic-grade, high-performance skincare amid stable operational sales reported through Q3 2025.